tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Konstantinos Aprilakis, 18 are a BUY (75%), 4 are a HOLD (16.67%), 2 are a SELL (8.33%).
Analyst Konstantinos Aprilakis, carries an average stock price target met ratio of 46.88% that have a potential upside of 73.72% achieved within 410 days. Previously, Konstantinos Aprilakis worked at STIFEL, DEUTSCHE BANK, JMP.
Konstantinos Aprilakis’s has documented 52 price targets and ratings displayed on 9 stocks. The coverage was on Healthcare, Energy sectors.
Most recent stock forecast was given on STRO, Sutro Biopharma at 21-Jan-2021.
Analyst best performing recommendations are on BPMC (BLUEPRINT MEDICINES CORP).
The best stock recommendation documented was for BPMC (BLUEPRINT MEDICINES CORP) at 10/29/2019. The price target of $75 was fulfilled within 17 days with a profit of $8.27 (12.39%) receiving and performance score of 7.29.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Oct-2023
$129
$-0.46 (-0.36%)
$151
1 years 3 months 4 days ago
(17-Jun-2025)
10/11 (90.91%)
$0.77 (0.60%)
110
Hold Since 24-Oct-2024
$129
$-0.46 (-0.36%)
$88
1 years 3 months 16 days ago
(05-Jun-2025)
2/2 (100%)
$1.1 (0.86%)
21
Hold Since 20-Mar-2025
$129
$-0.46 (-0.36%)
$102
1 years 3 months 16 days ago
(05-Jun-2025)
3/3 (100%)
$1.1 (0.86%)
27
Sell Since 10-Jun-2022
$129
$-0.46 (-0.36%)
$83
1 years 3 months 17 days ago
(04-Jun-2025)
14/17 (82.35%)
$0.9 (0.70%)
197
Buy Since 22-Oct-2019
$125
1 years 3 months 18 days ago
(03-Jun-2025)
17/19 (89.47%)
$20.36 (19.46%)
277
